VALGANCICLOVIR is a Oral For Solution in the Human Prescription Drug category. It is labeled and distributed by Airis Pharma Pvt Ltd. The primary component is Valganciclovir Hydrochloride.
Product ID | 71151-003_d94fb558-d963-5c7a-e053-2a95a90a04b4 |
NDC | 71151-003 |
Product Type | Human Prescription Drug |
Proprietary Name | VALGANCICLOVIR |
Generic Name | Valganciclovir |
Dosage Form | For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-02-28 |
Marketing Category | ANDA / |
Application Number | ANDA210169 |
Labeler Name | airis PHARMA PVT LTD |
Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-02-28 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0603-6330 | Valganciclovir | Valganciclovir hydrochloride |
0904-6796 | Valganciclovir | Valganciclovir |
16714-765 | Valganciclovir | Valganciclovir |
27241-158 | Valganciclovir | Valganciclovir |
31722-832 | Valganciclovir | Valganciclovir |
31722-837 | VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE |
42291-875 | Valganciclovir | Valganciclovir hydrochloride |
48433-124 | Valganciclovir | Valganciclovir |
50268-787 | Valganciclovir | Valganciclovir |
55111-762 | Valganciclovir | Valganciclovir |
59651-444 | Valganciclovir | Valganciclovir hydrochloride powder, |
60429-846 | Valganciclovir | Valganciclovir |
63629-2288 | Valganciclovir | Valganciclovir hydrochloride |
63739-076 | Valganciclovir | Valganciclovir |
64380-153 | Valganciclovir | Valganciclovir hydrochloride |
68084-965 | Valganciclovir | Valganciclovir |
69097-277 | Valganciclovir | Valganciclovir |
0004-0038 | Valcyte | valganciclovir |